Mesoblast (MESO) Other Non Operating Income (2016 - 2025)
Mesoblast (MESO) posted quarterly Other Non Operating Income of $10.3 million for Q4 2025, up 596.67% on a QoQ basis from $1.5 million in Q4 2023.
Mesoblast (MESO) Other Non Operating Income (2016 - 2025) Analysis & Trends
Mesoblast (MESO) has reported Other Non Operating Income for 9 consecutive years, with $10.3 million the latest figure, recorded in Q4 2025.
- Quarterly Other Non Operating Income changed N/A year-over-year to $10.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $10.3 million (changed N/A YoY) and the FY2022 annual result came in at $5.9 million, up 486.88% from the prior year.
- Other Non Operating Income improved to $10.3 million in Q4 2025 per MESO's latest filing, from $1.5 million in the prior quarter.
- Over the last five years, Other Non Operating Income for MESO reached as high as $10.3 million in Q4 2025 and fell as low as -$401000.0 in Q3 2022.
- A 4-year average of $2.5 million and a median of $1.5 million in 2022 frame the typical range for Other Non Operating Income.
- The largest YoY upside for Other Non Operating Income was 138.05% in 2021 against a maximum downside of 185.54% in 2021.
- Year by year, Other Non Operating Income stood at $2.2 million in 2021, then sank by 31.55% to $1.5 million in 2022, then changed by 0.0% to $1.5 million in 2023, then soared by 596.67% to $10.3 million in 2025.
- According to Business Quant data, Other Non Operating Income over the past three periods registered $10.3 million, $1.5 million, and $1.5 million for Q4 2025, Q4 2023, and Q1 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Mesoblast | 2.08 Bn | 1.95 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 10.26 Mn |
| Dec 31, 2023 | 1.47 Mn |
| Mar 31, 2023 | 1.47 Mn |
| Dec 31, 2022 | 1.47 Mn |
| Sep 30, 2022 | -401,000.00 |
| Jun 30, 2022 | 5.89 Mn |
| Mar 31, 2022 | 896,000.00 |
| Dec 31, 2021 | 2.15 Mn |
| Sep 30, 2021 | -349,000.00 |
| Dec 31, 2020 | 904,000.00 |
| Sep 30, 2020 | 408,000.00 |
| Jun 30, 2019 | -33,000.00 |
| Sep 30, 2018 | -23,000.00 |
| Jun 30, 2018 | -334,000.00 |
| Sep 30, 2017 | -358,000.00 |
| Jun 30, 2017 | -52,000.00 |
| Jun 30, 2016 | -381,000.00 |